Canada - CCT - Dr. Wolf

Study identifier:5077CN/0012

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Canada - CCT - Dr. Wolf

Medical condition

schizophrenia

Phase

N/A

Healthy volunteers

-

Study drug

-

Sex

-

Actual enrollment

-

Study type

-

Age

-

Date

Study Start Date: 01 Jul 2002
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

-

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria